Market Chatter: Chong Kun Dang Pharmaceutical to Supply Anemia Biosimilar Drug in Middle East-- Chong Kun Dang Pharmaceutical has agreed to supply its anemia biosimilar Nesbell drug to Oman-based Menagene Pharmaceutical Industries, Pulse News reported Monday. The South Korean...